IDEXX Laboratories (IDXX) Revenue — Quarter Ended Dec 31, 2024
Revenue for the quarter decreased compared to the immediately preceding quarter. However, revenue rose relative to the same quarter one year earlier.
Key takeaway
Quarter ended Dec 31, 2024 · FY2024 Q4
Revenue for the quarter decreased compared to the immediately preceding quarter. However, revenue rose relative to the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$954.3M
Revenue reported for this quarter.
Quarter-over-quarter
-2.2%
Change from the immediately preceding quarter.
Year-over-year
+5.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$3.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2024 | $964.1M | +7.1% |
| Jun 30, 2024 | $1B | +6.4% |
| Sep 30, 2024 | $975.5M | +6.6% |
| Dec 31, 2024 | $954.3M | +5.8% |
Revenue performance
The reported revenue fell from the prior quarter, marking a sequential decline. On a year-over-year basis, the figure showed an increase.
Quarterly comparison
Compared with the preceding quarter, revenue was lower. When measured against the same quarter of the prior year, revenue was higher.
What to watch
Filing context mentions management discussion and analysis of financial condition and results of operations.